Method for treating amyotrophic lateral sclerosis
作者： Benjamin Rix Brooks
DOI:
关键词:
摘要: The invention provides a method for treating amyotrophic lateral sclerosis in patient which comprises administering to the an effective amount of non-cysteine glutathione precursor or derivative so as increase intracellular levels and alleviate symptom sclerosis. substrate may be thiazolidine-4-carboxylate analog, analogs ester, pharmaceutically acceptable salt thereof.
lens.org 参考文章(34)
E. J. Levy, M. E. Anderson, A. Meister, Transport of Glutathione Diethyl Ester Into Human Cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 9171- 9175 ,(1993) , 10.1073/PNAS.90.19.9171
G R Bernard, W D Lucht, M E Niedermeyer, J R Snapper, M L Ogletree, K L Brigham, Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. Journal of Clinical Investigation. ,vol. 73, pp. 1772- 1784 ,(1984) , 10.1172/JCI111386
David R Borchelt, Michael Guarnieri, Philip C Wong, Michael K Lee, Hilda S Slunt, Zuo-Shang Xu, Sangram S Sisodia, Donald L Price, Don W Cleveland, None, Superoxide Dismutase 1 Subunits with Mutations Linked to Familial Amyotrophic Lateral Sclerosis Do Not Affect Wild-type Subunit Function Journal of Biological Chemistry. ,vol. 270, pp. 3234- 3238 ,(1995) , 10.1074/JBC.270.7.3234
Mary E. Anderson, Fiona Powrie, Rajinder N. Puri, Alton Meister, Glutathione monoethyl ester: preparation, uptake by tissues, and conversion to glutathione. Archives of Biochemistry and Biophysics. ,vol. 239, pp. 538- 548 ,(1985) , 10.1016/0003-9861(85)90723-4
J. M. Williamson, A. Meister, Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate Proceedings of the National Academy of Sciences of the United States of America. ,vol. 78, pp. 936- 939 ,(1981) , 10.1073/PNAS.78.2.936
J. D. Rothstein, L. Jin, M. Dykes-Hoberg, R. W. Kuncl, Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 6591- 6595 ,(1993) , 10.1073/PNAS.90.14.6591
E. S. Louwerse, G. J. Weverling, P. M. M. Bossuyt, F. E. P. Meyjes, J. M. B. V. de Jong, Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis JAMA Neurology. ,vol. 52, pp. 559- 564 ,(1995) , 10.1001/ARCHNEUR.1995.00540300031009
Daniel R. Rosen, Teepu Siddique, David Patterson, Denise A. Figlewicz, Peter Sapp, Afif Hentati, Deirdre Donaldson, Jun Goto, Jeremiah P. O'Regan, Han-Xiang Deng, Zohra Rahmani, Aldis Krizus, Diane McKenna-Yasek, Annarueber Cayabyab, Sandra M. Gaston, Ralph Berger, Rudolph E. Tanzi, John J. Halperin, Brian Herzfeldt, Raymond Van den Bergh, Wu-Yen Hung, Thomas Bird, Gang Deng, Donald W. Mulder, Celestine Smyth, Nigel G. Laing, Edwin Soriano, Margaret A. Pericak–Vance, Jonathan Haines, Guy A. Rouleau, James S. Gusella, H. Robert Horvitz, Robert H. Brown, Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature. ,vol. 362, pp. 59- 62 ,(1993) , 10.1038/362059A0
Alton Meister, Joanne M. Williamson, Cysteine delivery system ,(1982)
Allen C. Bowling, Jorg B. Schulz, Robert H. Brown, M. Flint Beal, Superoxide Dismutase Activity, Oxidative Damage, and Mitochondrial Energy Metabolism in Familial and Sporadic Amyotrophic Lateral Sclerosis Journal of Neurochemistry. ,vol. 61, pp. 2322- 2325 ,(1993) , 10.1111/J.1471-4159.1993.TB07478.X